Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan:133:110974.
doi: 10.1016/j.biopha.2020.110974. Epub 2020 Nov 11.

Kefir: A protective dietary supplementation against viral infection

Affiliations
Review

Kefir: A protective dietary supplementation against viral infection

Reham Samir Hamida et al. Biomed Pharmacother. 2021 Jan.

Abstract

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a recently discovered coronavirus termed 'severe acute respiratory syndrome coronavirus 2' (SARS-CoV-2). Several scholars have tested antiviral drugs and compounds to overcome COVID-19. 'Kefir' is a fermented milk drink similar to a thin yogurt that is made from kefir grains. Kefir and its probiotic contents can modulate the immune system to suppress infections from viruses (e.g., Zika, hepatitis C, influenza, rotaviruses). The antiviral mechanisms of kefir involve enhancement of macrophage production, increasing phagocytosis, boosting production of cluster of differentiation-positive (CD4+), CD8+, immunoglobulin (Ig)G+ and IgA+ B cells, T cells, neutrophils, as well as cytokines (e.g., interleukin (IL)-2, IL-12, interferon gamma-γ). Kefir can act as an anti-inflammatory agent by reducing expression of IL-6, IL-1, TNF-α, and interferon-γ. Hence, kefir might be a significant inhibitor of the 'cytokine storm' that contributes to COVID-19. Here, we review several studies with a particular emphasis on the effect of kefir consumption and their microbial composition against viral infection, as well as discussing the further development of kefir as a protective supplementary dietary against SARS-CoV-2 infection via modulating the immune response.

Keywords: Anti-inflammatory; Antiviral activity; Coronaviru; Immune system; Kefir.

PubMed Disclaimer

Conflict of interest statement

The authors report no declarations of interest.

Figures

None
Graphical abstract
Fig. 1
Fig. 1
Structure of SARS-CoV-2.
Fig. 2
Fig. 2
Lifecycle of coronaviruses.
Fig. 3
Fig. 3
Potential mechanism of action of kefir against viral infection. (A) Kefir enhances the immune response by stimulating cytokine production, including interferon gamma (IFN-γ), interleukin (IL)-2, and IL-12. (B) Kefir inhibits the inflammatory response by suppressing cytokine production, such as IL-6, IL-1 and tumour necrosis factor (TNF)-α.
Fig. 4
Fig. 4
Antiviral activities of kefir.

References

    1. Kanauchi O., Andoh A., AbuBakar S., Yamamoto N. Probiotics and paraprobiotics in viral infection: clinical application and effects on the innate and acquired immune systems. Curr. Pharm. Des. 2018;24(6):710–717. - PMC - PubMed
    1. Jamison D.T., Breman J.G., Measham A.R., Alleyne G., Claeson M., Evans D.B. The World Bank; 2006. Disease Control Priorities in Developing Countries. - PubMed
    1. Pyrc K., Berkhout B., van der Hoek L. Identification of new human coronaviruses. Expert Rev. Anti. Ther. 2007;5(2):245–253. - PubMed
    1. Chen Y., Liu Q., Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J. Med. Virol. 2020;92(4):418–423. - PMC - PubMed
    1. Gerna G., Campanini G., Rovida F., Percivalle E., Sarasini A., Marchi A. Genetic variability of human coronavirus OC43‐, 229E‐, and NL63‐like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients. J. Med. Virol. 2006;78(7):938–949. - PMC - PubMed